Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Total Debt: 2020

Historic Total Debt for Caribou Biosciences (CRBU) over the last 1 years, with Dec 2020 value amounting to $924,000.

  • Caribou Biosciences' Total Debt was N/A to $924,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $924,000, marking a year-over-year change of. This contributed to the annual value of $924,000 for FY2020, which is N/A change from last year.
  • Per Caribou Biosciences' latest filing, its Total Debt stood at $924,000 for FY2020.
  • Over the past 5 years, Caribou Biosciences' Total Debt peaked at $924,000 during FY2020, and registered a low of $924,000 during FY2020.
  • Moreover, its 1-year median value for Total Debt was $924,000 (2020), whereas its average is $924,000.